Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2014

Open Access 01-12-2014 | Research

Rescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat

Authors: Peter J Mark, Caitlin S Wyrwoll, Intan S Zulkafli, Trevor A Mori, Brendan J Waddell

Published in: Reproductive Biology and Endocrinology | Issue 1/2014

Login to get access

Abstract

Background

Adverse fetal environments predispose offspring to pathologies associated with the metabolic syndrome. Previously we demonstrated that adult offspring of dexamethasone-treated mothers had elevated plasma insulin and pro-inflammatory cytokines, effects prevented by a postnatal diet enriched with omega (n)-3 fatty acids. Here we tested whether prenatal glucocorticoid excess also programmed the adipose tissue phenotype, and whether this outcome is rescued by dietary n-3 fatty acids.

Methods

Offspring of control and dexamethasone-treated mothers (0.75 μg/ml in drinking water, day 13 to term) were cross-fostered to mothers on a standard (Std) or high n-3 (Hn3) diet at birth. Offspring remained on these diets post-weaning, and serum and retroperitoneal fat were obtained at 6 months of age (n = 5-8 per group). Serum was analysed for blood lipids and fatty acid profiles, adipocyte cross sectional area was measured by unbiased stereological analysis and adipose expression of markers of inflammation, glucocorticoid sensitivity and lipid metabolism were determined by RT-qPCR analysis.

Results

Serum total fatty acid levels were elevated (P < 0.01) in male offspring of dexamethasone-treated mothers, an effect prevented by Hn3 consumption. Prenatal dexamethasone also programmed increased adipose expression of Il6, Il1b (both P < 0.05) and Tnfa (P < 0.001) mRNAs regardless of fetal sex, but again this effect was prevented (for Il6 and Il1b) by Hn3 consumption. Offspring of dexamethasone-treated mothers had increased adipose expression of Gr (P = 0.008) and Ppara (P < 0.05) regardless of sex or postnatal diet, while 11bHsd1 was upregulated in males only. The Hn3 diet increased Ppard expression and reduced adipocyte size in all offspring (both P < 0.05) irrespective of prenatal treatment.

Conclusions

Prenatal glucocorticoid exposure programmed increased expression of inflammatory markers and enhanced glucocorticoid sensitivity of adipose tissue. Partial prevention of this phenotype by high n-3 consumption indicates that postnatal dietary manipulations can limit adverse fetal programming effects on adipose tissue.
Appendix
Available only for authorised users
Literature
1.
go back to reference Birdsall KM, Vyas S, Khazaezadeh N, Oteng-Ntim E: Maternal obesity: a review of interventions. Int J Clin Pract. 2009, 63: 494-507. 10.1111/j.1742-1241.2008.01910.x.CrossRefPubMed Birdsall KM, Vyas S, Khazaezadeh N, Oteng-Ntim E: Maternal obesity: a review of interventions. Int J Clin Pract. 2009, 63: 494-507. 10.1111/j.1742-1241.2008.01910.x.CrossRefPubMed
2.
go back to reference Thompson NM, Norman AM, Donkin SS, Shankar RR, Vickers MH, Miles JL, Breier BH: Prenatal and postnatal pathways to obesity: different underlying mechanisms, different metabolic outcomes. Endocrinology. 2007, 148: 2345-2354. 10.1210/en.2006-1641.CrossRefPubMed Thompson NM, Norman AM, Donkin SS, Shankar RR, Vickers MH, Miles JL, Breier BH: Prenatal and postnatal pathways to obesity: different underlying mechanisms, different metabolic outcomes. Endocrinology. 2007, 148: 2345-2354. 10.1210/en.2006-1641.CrossRefPubMed
3.
go back to reference Vuguin P, Raab E, Liu B, Barzilai N, Simmons R: Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. Diabetes. 2004, 53: 2617-2622. 10.2337/diabetes.53.10.2617.CrossRefPubMed Vuguin P, Raab E, Liu B, Barzilai N, Simmons R: Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. Diabetes. 2004, 53: 2617-2622. 10.2337/diabetes.53.10.2617.CrossRefPubMed
4.
go back to reference Wyrwoll CS, Mark PJ, Mori TA, Puddey IB, Waddell BJ: Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology. 2006, 147: 599-606. 10.1210/en.2005-0748.CrossRefPubMed Wyrwoll CS, Mark PJ, Mori TA, Puddey IB, Waddell BJ: Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology. 2006, 147: 599-606. 10.1210/en.2005-0748.CrossRefPubMed
5.
go back to reference Wyrwoll CS, Mark PJ, Mori TA, Waddell BJ: Developmental programming of adult hyperinsulinemia, increased proinflammatory cytokine production, and altered skeletal muscle expression of SLC2A4 (GLUT4) and uncoupling protein 3. J Endocrinol. 2008, 198: 571-579. 10.1677/JOE-08-0210.CrossRefPubMed Wyrwoll CS, Mark PJ, Mori TA, Waddell BJ: Developmental programming of adult hyperinsulinemia, increased proinflammatory cytokine production, and altered skeletal muscle expression of SLC2A4 (GLUT4) and uncoupling protein 3. J Endocrinol. 2008, 198: 571-579. 10.1677/JOE-08-0210.CrossRefPubMed
6.
go back to reference Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR: Changing glucocorticoid action: 11beta-Hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol. 2013, 137: 82-92.PubMedCentralCrossRefPubMed Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR: Changing glucocorticoid action: 11beta-Hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol. 2013, 137: 82-92.PubMedCentralCrossRefPubMed
7.
go back to reference Burton PJ, Waddell BJ: 11 beta-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. J Endocrinol. 1994, 143: 505-513. 10.1677/joe.0.1430505.CrossRefPubMed Burton PJ, Waddell BJ: 11 beta-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. J Endocrinol. 1994, 143: 505-513. 10.1677/joe.0.1430505.CrossRefPubMed
8.
go back to reference Smith JT, Waddell BJ: Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology. 2000, 141: 2422-2428. 10.1210/endo.141.7.7541.CrossRefPubMed Smith JT, Waddell BJ: Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology. 2000, 141: 2422-2428. 10.1210/endo.141.7.7541.CrossRefPubMed
9.
go back to reference Warnick GR, Albers JJ: A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978, 19: 65-76.PubMed Warnick GR, Albers JJ: A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978, 19: 65-76.PubMed
10.
go back to reference Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ: Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002, 76: 1007-1015.PubMed Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ: Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002, 76: 1007-1015.PubMed
11.
go back to reference Gundersen HJ, Jensen EB: The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987, 147: 229-263. 10.1111/j.1365-2818.1987.tb02837.x.CrossRefPubMed Gundersen HJ, Jensen EB: The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987, 147: 229-263. 10.1111/j.1365-2818.1987.tb02837.x.CrossRefPubMed
12.
go back to reference Weibel ER: Stereological Methods: Practical Methods for Biological Morphometry. 1979, London - New York - Toronto: Academic Press Weibel ER: Stereological Methods: Practical Methods for Biological Morphometry. 1979, London - New York - Toronto: Academic Press
13.
go back to reference Kinosita K, Tsong TY: Survival of sucrose-loaded erythrocytes in the circulation. Nature. 1978, 272: 258-260. 10.1038/272258a0.CrossRefPubMed Kinosita K, Tsong TY: Survival of sucrose-loaded erythrocytes in the circulation. Nature. 1978, 272: 258-260. 10.1038/272258a0.CrossRefPubMed
14.
go back to reference Lareu RR, Harve KS, Raghunath M: Emulating a crowded intracellular environment in vitro dramatically improves RT-PCR performance. Biochem Biophys Res Commun. 2007, 363: 171-177. 10.1016/j.bbrc.2007.08.156.CrossRefPubMed Lareu RR, Harve KS, Raghunath M: Emulating a crowded intracellular environment in vitro dramatically improves RT-PCR performance. Biochem Biophys Res Commun. 2007, 363: 171-177. 10.1016/j.bbrc.2007.08.156.CrossRefPubMed
15.
go back to reference Rozen S, Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Edited by: Krawetz S, Misener S. 2000, Totowa: Humana Press, 365-386. Rozen S, Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Edited by: Krawetz S, Misener S. 2000, Totowa: Humana Press, 365-386.
16.
go back to reference Orly J, Rei Z, Greenberg NM, Richards JS: Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone- induced granulosa cell differentiation: use of reverse transcriptase- polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology. 1994, 134: 2336-2346.PubMed Orly J, Rei Z, Greenberg NM, Richards JS: Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone- induced granulosa cell differentiation: use of reverse transcriptase- polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology. 1994, 134: 2336-2346.PubMed
17.
go back to reference Snedecor G, Cochrane W: Statistical Methods. 1989, Ames: Iowa State University Press Snedecor G, Cochrane W: Statistical Methods. 1989, Ames: Iowa State University Press
18.
go back to reference Breier BH, Vickers MH, Ikenasio BA, Chan KY, Wong WP: Fetal programming of appetite and obesity. Mol Cell Endocrinol. 2001, 185: 73-79. 10.1016/S0303-7207(01)00634-7.CrossRefPubMed Breier BH, Vickers MH, Ikenasio BA, Chan KY, Wong WP: Fetal programming of appetite and obesity. Mol Cell Endocrinol. 2001, 185: 73-79. 10.1016/S0303-7207(01)00634-7.CrossRefPubMed
19.
go back to reference Vickers MH, Krechowec SO, Breier BH: Is later obesity programmed in utero?. Curr Drug Targets. 2007, 8: 923-934. 10.2174/138945007781386857.CrossRefPubMed Vickers MH, Krechowec SO, Breier BH: Is later obesity programmed in utero?. Curr Drug Targets. 2007, 8: 923-934. 10.2174/138945007781386857.CrossRefPubMed
20.
go back to reference Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Bjorntorp P, Albertsson Wikland K, Holmang A: Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab. 2001, 281: E326-E334.PubMed Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Bjorntorp P, Albertsson Wikland K, Holmang A: Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab. 2001, 281: E326-E334.PubMed
21.
go back to reference Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD: Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000, 279: E83-E87.PubMed Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD: Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000, 279: E83-E87.PubMed
22.
go back to reference Lukaszewski MA, Mayeur S, Fajardy I, Delahaye F, Dutriez-Casteloot I, Montel V, Dickes-Coopman A, Laborie C, Lesage J, Vieau D, Breton C: Maternal prenatal undernutrition programs adipose tissue gene expression in adult male rat offspring under high-fat diet. Am J Physiol Endocrinol Metab. 2011, 301: E548-E559. 10.1152/ajpendo.00011.2011.CrossRefPubMed Lukaszewski MA, Mayeur S, Fajardy I, Delahaye F, Dutriez-Casteloot I, Montel V, Dickes-Coopman A, Laborie C, Lesage J, Vieau D, Breton C: Maternal prenatal undernutrition programs adipose tissue gene expression in adult male rat offspring under high-fat diet. Am J Physiol Endocrinol Metab. 2011, 301: E548-E559. 10.1152/ajpendo.00011.2011.CrossRefPubMed
23.
go back to reference Mark PJ, Augustus S, Lewis JL, Hewitt DP, Waddell BJ: Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone. Biol Reprod. 2009, 80: 1209-1215. 10.1095/biolreprod.108.073650.PubMedCentralCrossRefPubMed Mark PJ, Augustus S, Lewis JL, Hewitt DP, Waddell BJ: Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone. Biol Reprod. 2009, 80: 1209-1215. 10.1095/biolreprod.108.073650.PubMedCentralCrossRefPubMed
24.
go back to reference Fan C, Zirpoli H, Qi K: n-3 fatty acids modulate adipose tissue inflammation and oxidative stress. Curr Opin Clin Nutr Metab Care. 2013, 16: 124-132. 10.1097/MCO.0b013e32835c02c8.CrossRefPubMed Fan C, Zirpoli H, Qi K: n-3 fatty acids modulate adipose tissue inflammation and oxidative stress. Curr Opin Clin Nutr Metab Care. 2013, 16: 124-132. 10.1097/MCO.0b013e32835c02c8.CrossRefPubMed
25.
go back to reference Boullu-Ciocca S, Paulmyer-Lacroix O, Fina F, Ouafik L, Alessi MC, Oliver C, Grino M: Expression of the mRNAs coding for the glucocorticoid receptor isoforms in obesity. Obes Res. 2003, 11: 925-929. 10.1038/oby.2003.127.CrossRefPubMed Boullu-Ciocca S, Paulmyer-Lacroix O, Fina F, Ouafik L, Alessi MC, Oliver C, Grino M: Expression of the mRNAs coding for the glucocorticoid receptor isoforms in obesity. Obes Res. 2003, 11: 925-929. 10.1038/oby.2003.127.CrossRefPubMed
26.
go back to reference Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ: Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A. 2004, 101: 7088-7093. 10.1073/pnas.0305524101.PubMedCentralCrossRefPubMed Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ: Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A. 2004, 101: 7088-7093. 10.1073/pnas.0305524101.PubMedCentralCrossRefPubMed
27.
go back to reference Seckl JR, Walker BR: Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001, 142: 1371-1376.PubMed Seckl JR, Walker BR: Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001, 142: 1371-1376.PubMed
28.
go back to reference Burton PJ, Waddell BJ: Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod. 1999, 60: 234-240. 10.1095/biolreprod60.2.234.CrossRefPubMed Burton PJ, Waddell BJ: Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod. 1999, 60: 234-240. 10.1095/biolreprod60.2.234.CrossRefPubMed
29.
go back to reference Waddell B, Bollen M, Wyrwoll C, Mori T, Mark P: Developmental programming of adult adrenal structure and steroidogenesis: effects of fetal glucocorticoid excess and postnatal dietary omega-3 fatty acids. J Endocrinol. 2010, 205 (2): 171-178. 10.1677/JOE-09-0459.CrossRefPubMed Waddell B, Bollen M, Wyrwoll C, Mori T, Mark P: Developmental programming of adult adrenal structure and steroidogenesis: effects of fetal glucocorticoid excess and postnatal dietary omega-3 fatty acids. J Endocrinol. 2010, 205 (2): 171-178. 10.1677/JOE-09-0459.CrossRefPubMed
30.
go back to reference Gnanalingham MG, Mostyn A, Symonds ME, Stephenson T: Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein-2. Am J Physiol Regul Integr Comp Physiol. 2005, 289: R1407-R1415. 10.1152/ajpregu.00375.2005.CrossRefPubMed Gnanalingham MG, Mostyn A, Symonds ME, Stephenson T: Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein-2. Am J Physiol Regul Integr Comp Physiol. 2005, 289: R1407-R1415. 10.1152/ajpregu.00375.2005.CrossRefPubMed
31.
go back to reference Wyrwoll CS, Mark PJ, Waddell BJ: Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system. Hypertension. 2007, 50: 579-584. 10.1161/HYPERTENSIONAHA.107.091603.CrossRefPubMed Wyrwoll CS, Mark PJ, Waddell BJ: Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system. Hypertension. 2007, 50: 579-584. 10.1161/HYPERTENSIONAHA.107.091603.CrossRefPubMed
32.
go back to reference Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR: Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest. 1998, 101: 2174-2181. 10.1172/JCI1567.PubMedCentralCrossRefPubMed Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR: Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest. 1998, 101: 2174-2181. 10.1172/JCI1567.PubMedCentralCrossRefPubMed
33.
go back to reference Mark PJ, Lewis JL, Jones ML, Keelan JA, Waddell BJ: The inflammatory state of the rat placenta increases in late gestation and is further enhanced by glucocorticoids in the labyrinth zone. Placenta. 2013, 34 (7): 559-566. 10.1016/j.placenta.2013.04.006.CrossRefPubMed Mark PJ, Lewis JL, Jones ML, Keelan JA, Waddell BJ: The inflammatory state of the rat placenta increases in late gestation and is further enhanced by glucocorticoids in the labyrinth zone. Placenta. 2013, 34 (7): 559-566. 10.1016/j.placenta.2013.04.006.CrossRefPubMed
34.
35.
go back to reference Jacobi D, Stanya KJ, Lee CH: Adipose tissue signaling by nuclear receptors in metabolic complications of obesity. Adipocyte. 2012, 1: 4-12. 10.4161/adip.19036.PubMedCentralCrossRefPubMed Jacobi D, Stanya KJ, Lee CH: Adipose tissue signaling by nuclear receptors in metabolic complications of obesity. Adipocyte. 2012, 1: 4-12. 10.4161/adip.19036.PubMedCentralCrossRefPubMed
36.
go back to reference Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A: Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature. 1998, 393: 790-793. 10.1038/31701.CrossRefPubMed Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A: Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature. 1998, 393: 790-793. 10.1038/31701.CrossRefPubMed
37.
go back to reference Blaak E: Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001, 4: 499-502. 10.1097/00075197-200111000-00006.CrossRefPubMed Blaak E: Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001, 4: 499-502. 10.1097/00075197-200111000-00006.CrossRefPubMed
38.
go back to reference Benkalfat NB, Merzouk H, Bouanane S, Merzouk SA, Bellenger J, Gresti J, Tessier C, Narce M: Altered adipose tissue metabolism in offspring of dietary obese rat dams. Clin Sci (Lond). 2011, 121: 19-28. 10.1042/CS20100534.CrossRef Benkalfat NB, Merzouk H, Bouanane S, Merzouk SA, Bellenger J, Gresti J, Tessier C, Narce M: Altered adipose tissue metabolism in offspring of dietary obese rat dams. Clin Sci (Lond). 2011, 121: 19-28. 10.1042/CS20100534.CrossRef
39.
go back to reference Evans RD, Williamson DH: Comparison of effects of platelet-activating factor and tumour necrosis factor-alpha on lipid metabolism in adrenalectomized rats in vivo. Biochim Biophys Acta. 1991, 1086: 191-196. 10.1016/0005-2760(91)90007-5.CrossRefPubMed Evans RD, Williamson DH: Comparison of effects of platelet-activating factor and tumour necrosis factor-alpha on lipid metabolism in adrenalectomized rats in vivo. Biochim Biophys Acta. 1991, 1086: 191-196. 10.1016/0005-2760(91)90007-5.CrossRefPubMed
40.
go back to reference Plomgaard P, Fischer CP, Ibfelt T, Pedersen BK, van Hall G: Tumor necrosis factor-alpha modulates human in vivo lipolysis. J Clin Endocrinol Metab. 2008, 93: 543-549. 10.1210/jc.2007-1761.CrossRefPubMed Plomgaard P, Fischer CP, Ibfelt T, Pedersen BK, van Hall G: Tumor necrosis factor-alpha modulates human in vivo lipolysis. J Clin Endocrinol Metab. 2008, 93: 543-549. 10.1210/jc.2007-1761.CrossRefPubMed
41.
go back to reference Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997, 65: 1645S-1654S.PubMed Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997, 65: 1645S-1654S.PubMed
42.
go back to reference Rustan AC, Nossen JO, Christiansen EN, Drevon CA: Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res. 1988, 29: 1417-1426.PubMed Rustan AC, Nossen JO, Christiansen EN, Drevon CA: Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res. 1988, 29: 1417-1426.PubMed
43.
go back to reference Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T: Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J Agric Food Chem. 2007, 55: 7170-7176. 10.1021/jf071225x.CrossRefPubMed Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T: Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J Agric Food Chem. 2007, 55: 7170-7176. 10.1021/jf071225x.CrossRefPubMed
44.
go back to reference Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM: Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003, 113: 159-170. 10.1016/S0092-8674(03)00269-1.CrossRefPubMed Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM: Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003, 113: 159-170. 10.1016/S0092-8674(03)00269-1.CrossRefPubMed
45.
go back to reference Flachs P, Rossmeisl M, Bryhn M, Kopecky J: Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond). 2009, 116: 1-16. 10.1042/CS20070456.CrossRef Flachs P, Rossmeisl M, Bryhn M, Kopecky J: Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond). 2009, 116: 1-16. 10.1042/CS20070456.CrossRef
46.
go back to reference Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE: Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2000, 43: 1498-1506.CrossRefPubMed Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE: Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 2000, 43: 1498-1506.CrossRefPubMed
47.
go back to reference Lonn M, Mehlig K, Bengtsson C, Lissner L: Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J. 2009, 24 (1): 326-331.CrossRefPubMed Lonn M, Mehlig K, Bengtsson C, Lissner L: Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J. 2009, 24 (1): 326-331.CrossRefPubMed
48.
go back to reference Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lönn M: Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J. 2006, 20: 1540-1542. 10.1096/fj.05-5678fje.CrossRefPubMed Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lönn M: Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J. 2006, 20: 1540-1542. 10.1096/fj.05-5678fje.CrossRefPubMed
49.
go back to reference Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, Kovacs M, Vargha P, Szekeres O, Speer G, Karádi I, Sikter M, Kaszás E, Dworak O, Gerö G, Cseh K: Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2003, 149: 129-135. 10.1530/eje.0.1490129.CrossRefPubMed Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, Kovacs M, Vargha P, Szekeres O, Speer G, Karádi I, Sikter M, Kaszás E, Dworak O, Gerö G, Cseh K: Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2003, 149: 129-135. 10.1530/eje.0.1490129.CrossRefPubMed
Metadata
Title
Rescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat
Authors
Peter J Mark
Caitlin S Wyrwoll
Intan S Zulkafli
Trevor A Mori
Brendan J Waddell
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2014
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-12-39

Other articles of this Issue 1/2014

Reproductive Biology and Endocrinology 1/2014 Go to the issue